The intended purpose of this issue is to raise awareness of radiation therapy and to provide current perspectives on some of its most important topics related to prostate cancer. Whether you are the most seasoned senior clinician or junior trainee, this issue is a resource for reviewing the literature, formulating practice patterns and educating patients. And, translational scientists and clinical researchers who are considering the future of prostate radiation therapy have a concise collective of ideas and opinion from well-recognized and leading experts in the field
Guest Editor
Mark K. Buyyounouski, MD, MSProfessor and Director of Genitourinary Cancers, Department of Radiation Oncology, Stanford University, Stanford, CA 94304, USA